All stock lists
Unlock the score
enGene Therapeutics Inc. (NASDAQ:ENGN)
CA · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.58+0.02 (+1.28%)
Market cap
$106M
Insider Score
Health Score
Analyst consensus
Listed since
Feb 1, 2022
Website
Insider Score
/ 100
ENGN Insider Score
enGene Therapeutics Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
enGene Therapeutics Inc. Executive Compensation
Reading the latest SEC DEF 14A proxy…
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.